896
Views
35
CrossRef citations to date
0
Altmetric
Original Articles

Chitosan Based Delivery Systems on a Length Scale: Nano to Macro

, , , &
Pages 125-142 | Received 22 Feb 2011, Accepted 03 May 2011, Published online: 04 Jan 2013

References

  • Basavaraju , K.C. , Damappa , T. and Rai , S.K. 2006 . Preparation of chitosan and its miscibility studies with gelatin using viscosity, ultrasonic and refractive index . Carbohyd. Polym. , 66 ( 3 ) : 357 – 362 .
  • 2010 http://en.wikipedia.org/wiki/Chitosan (http://en.wikipedia.org/wiki/Chitosan)
  • Kofuji , K. , Isobe , T. and Murata , Y. 2009 . Controlled release of alpha-lipoic acid through incorporation into natural polysaccharide-based gel beads . Food Chem. , 115 ( 2 ) : 483 – 487 .
  • Zivanovic , S. 2007 . Physical, mechanical, and antibacterial properties of chitosan/PEO blend films . Biomacromolecules , 8 ( 5 ) : 1505 – 1510 .
  • Martinou , A. , Kafetzopoulos , D. and Bouriotis , V. 1995 . Chitin deacetylation by enzymatic means: monitoring of deacetylation processes . Carbohyd. Res. , 273 ( 2 ) : 235 – 242 .
  • Miya , M. 1980 . I.R. spectroscopic determination of CONH content in highly deacylated chitosan . Int. J. Biol. Macromol. , 2 ( 5 ) : 323 – 324 .
  • Gupta , K.C. and Jabrail , F.H. 2006 . Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman . Carbohyd. Res. , 341 ( 6 ) : 744 – 756 .
  • Lavertu , M. 2003 . A validated 1H NMR method for the determination of the degree of deacetylation of chitosan . J. Pharm. Biomed. Anal. , 32 ( 6 ) : 1149 – 1158 .
  • Zhang , Y. 2011 . Determination of the degree of deacetylation of chitosan by potentiometric titration preceded by enzymatic pretreatment . Carbohyd. Polym. , 83 ( 2 ) : 813 – 817 .
  • Muzzarelli , R.A.A. and Peter , M. G. 1997 . Chitin Handbook , Bremin : European Chitin Society .
  • Pal , K. , Banthia , A.K. and Majumdar , D.K. 2009 . Polymeric Hydrogels: Characterization and Biomedical Applications . Des. Monomers .Polym. , 12 : 197 – 220 .
  • Li , L.-H. 2010 . Preparation, characterization and antimicrobial activities of chitosan/Ag/ZnO blend films . Chem. Eng. J. , 160 ( 1 ) : 378 – 382 .
  • Lee , K.W. and Yoon , J.J. 2004 . Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan . Transplantation Proceedings , 36 ( 8 ) : 2464 – 2465 .
  • Agnihotri , S.A. , Mallikarjuna , N.N. and Aminabhavi , T.M. 2004 . Recent advances on chitosan-based micro-and nanoparticles in drug delivery . J. Control. Release , 100 ( 1 ) : 5 – 28 .
  • Felt , O. , Buri , P. and Gurny , R. 1998 . Chitosan: A unique polysaccharide for drug delivery . Drug Development and Industrial Pharmacy , 24 ( 11 ) : 979 – 993 .
  • Li , F. , Liu , W.G. and Yao , K.D. 2002 . Preparation of oxidized glucose-crosslinked N-alkylated chitosan membrane and in vitro studies of pH-sensitive drug delivery behaviour . Biomaterials , 23 ( 2 ) : 343 – 347 .
  • Lorenzo-Lamosa , M. 1998 . Design of microencapsulated chitosan microspheres for colonic drug delivery . J. Control. Release , 52 ( 1–2 ) : 109 – 118 .
  • Roy , K. 1999 . Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy . Nature Med. , 5 ( 4 ) : 387
  • Erbacher , P. 1998 . Chitosan-based vector/DNA complexes for gene delivery: Biophysical characteristics and transfection ability . Pharm. Res. , 15 ( 9 ) : 1332 – 1339 .
  • Acosta , E. 2009 . Bioavailability of nanoparticles in nutrient and nutraceutical delivery . Curr. Opinion Colloid Interface Sci. , 14 ( 1 ) : 3 – 15 .
  • CHSIR. Chitosan-Fat Blocker2010 http://www.chsir.com/chitosan.htm (http://www.chsir.com/chitosan.htm)
  • Ormrod , D.J. , Holmes , C.C. and Miller , T.E. Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis . Atherosclerosis , 138 ( 2 ) 329 – 334 .
  • Wuolijoki , E. , Hirveol , T. and Ylitaol , P. 1999 . Decrease in serum LDL cholesterol with microcrystalline chitosan . Methods Find Exp. Clin. Pharmacol. , 21 ( 5 ) : 357 – 361 .
  • Sciutto , G. and Colombo , P. 1995 . Lipid-lowering effect of chitosan dietary integrator and hypocaloric diet in obese subjects . Acta Toxicol. Ther. , 16 ( 4 ) : 215 – 230 .
  • Macchi , G. 1996 . A new approach to the treatment of obesity: Chitosan's effect on body weight reduction and plasma cholesterol levels . Acta Toxicol. Ther. , 17 ( 4 ) : 303 – 320 .
  • Zhou , Y. 2011 . Photopolymerized water-soluble chitosan-based hydrogel as potential use in tissue engineering . Int. J. Biol. Macromol. , 48 ( 3 ) : 408 – 413 .
  • Sudarshan , N.R. , Hoover , D.G. and Knorr , D. 1992 . Antibacterial action of chitosan . Food Biotechnol. , 6 ( 3 ) : 257 – 272 .
  • Zivanovic , S. 2004 . Molecular weight of chitosan influences antimicrobial activity in oil-in-water emulsions . J. Food Protect. , 67 : 952 – 959 .
  • Mohd Nasir , N.F. 2005 . Characterization of chitosan-poly (ethylene oxide) blends as haemodialysis membrane . Am. J. Appl. Sci. , 2 ( 12 ) : 1578 – 1583 .
  • Mi , F.-L. , Sung , H.-W. and Shyu , S.-S. 2000 . Synthesis and characterization of a novel chitosan-based network prepared using naturally occurring crosslinker . J. Polym. Sci. A , 38 ( 15 ) : 2804 – 2814 .
  • MonteiroJr , O.A.C. and Airoldi , C. 1999 . Some studies of crosslinking chitosan-glutaraldehyde interaction in a homogeneous system . Int. J. Biol. Macromol. , 26 ( 2–3 ) : 119 – 128 .
  • Park , S.-B. 2004 . Ca-alginate microspheres encapsulated in chitosan beads . J. Microencapsul. , 21 ( 5 ) : 485 – 497 .
  • Zhao , L. and Mitomo , H. 2009 . Hydrogels of dihydroxypropyl chitosan crosslinked with irradiation at paste-like condition . Carbohyd. Polym. , 76 ( 2 ) : 314 – 319 .
  • Jameela , S.R. 2002 . Preparation and evaluation of photocrosslinkable chitosan as a drug delivery matrix . J. Appl. Polym. Sci. , 86 ( 8 ) : 1873 – 1877 .
  • Salmawi , K.M.E. 2007 . Gamma Radiation-Induced Crosslinked PVA/Chitosan Blends for Wound Dressing . J. Macromol. Sci. A , 44 ( 5 ) : 541 – 545 .
  • Pulieri , E. 2008 . Chitosan/gelatin blends for biomedical applications . J. Biomed. Mat. Res. A , 86A ( 2 ) : 311 – 322 .
  • Peppas , N.A. 2000 . Hydrogels in pharmaceutical formulations . Eur. J. Pharm. Biopharm. , 50 ( 1 ) : 27 – 46 .
  • Hoffman , A.S. 2001 . Hydrogels for Biomedical Applications. Annals of the New York Academy of Sciences , 944 ( 1 ) : 62 – 73 .
  • Campoccia , D. 1998 . Semisynthetic resorbable materials from hyaluronan esterification . Biomaterials , 19 ( 23 ) : 2101 – 2127 .
  • Prestwich , G.D. 1998 . Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives . J. Control. Release , 53 ( 1–3 ) : 93 – 103 .
  • Trimukhe , K.D. and Varma , A.J. 2008 . Complexation of heavy metals by crosslinked chitin and its deacetylated derivatives . Carbohyd. Polym. , 71 ( 1 ) : 66 – 73 .
  • Kashyap , N. , Kumar , N. and Kumar , M.N.V.R. 2005 . Hydrogels for Pharmaceutical and Biomedical applications . Crit. Rev. Therapeut. Drug Carrier Syst. , 22 ( 2 ) : 107 – 149 .
  • Peppas , N.A. 1987 . Hydrogels in Medicine and Pharmacy , Vol. I–III , Boca Raton , FL : CRC Press .
  • Moura , M.J. , Figueiredo , M.M. and Gil , M.H. 2007 . Rheological Study of Genipin Cross-Linked Chitosan Hydrogels . Biomacromolecules , 8 ( 12 ) : 3823 – 3829 .
  • Muzzarelli , R.A.A. 2009 . Genipin-crosslinked chitosan hydrogels as biomedical and pharmaceutical aids . Carbohyd. Polym. , 77 ( 1 ) : 1 – 9 .
  • Bhumkar , D.R. and Pokharkar , V.B. 2006 . Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note . AAPS PharmSciTech. , 7 ( 2 ) : E1 – E6 .
  • Pandey , R. and Khuller , G.K. 2004 . Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers . J. Antimicrob. Chemother. , 53 ( 4 ) : 635 – 640 .
  • Zhu , Y. and Chan-Park , M.B. 2007 . Density quantification of collagen grafted on biodegradable polyester: Its application to esophageal smooth muscle cell . Anal. Biochem. , 363 ( 1 ) : 119 – 127 .
  • Pal , K. , Paulson , A.T. and Rousseau , D. 2009 . Modern Biopolymer Science: Bridging The Divide Between Fundamental Treatise And Industrial Application. 1st ed , Edited by: Kasapis , S. , Norton , I.T. and Ubbink , J.B . Academic Press: London .
  • Nassar , T. 2009 . Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug . J. Control. Release , 133 ( 1 ) : 77 – 84 .
  • Agnihotri , S.M. and Vavia , P.R. 2009 . Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application . Nanomed. Nanotechnol. Biol. Med. , 5 ( 1 ) : 90 – 95 .
  • Carrer , D.C. , Vermehren , C. and Bagatolli , L.A. 2008 . Pig skin structure and transdermal delivery of liposomes: A two photon microscopy study . J. Control. Release , 132 ( 1 ) : 12 – 20 .
  • Joshi , M.D. and Müller , R.H. 2009 . Lipid nanoparticles for parenteral delivery of actives . Eur. J. Pharm. Biopharm. , 71 ( 2 ) : 161 – 172 .
  • Allemann , E. , Gurny , R. and Doelker , E. 1993 . Drug-Loaded Nanoparticles- Preparation, Methods and Drug Targetting Issues . Eur. J. Pharm. Biopharm. , 39 ( 5 ) : 173 – 191 .
  • Kreuter , J. 1996 . Nanoparticles and microparticles for drug and vaccine delivery . J. Anat. , 189 ( Pt. 3 ) : 503 – 505 .
  • in-PharmaTechnologist. Nanotechnology to revolutionise drug delivery2010 http://www.in-pharmatechnologist.com/Materials-Formulation/Nanotechnology-to-revolutionise-drug-delivery (http://www.in-pharmatechnologist.com/Materials-Formulation/Nanotechnology-to-revolutionise-drug-delivery)
  • Kawashima , Y. 2001 . Nanoparticulate systems for improved drug delivery . Adv. Drug Deliv. Rev. , 47 ( 1 ) : 1 – 2 .
  • Wikipedia. Microparticles2010 http://en.wikipedia.org/wiki/Microparticles (http://en.wikipedia.org/wiki/Microparticles)
  • Brannon-Peppas , L. 1997 . Polymers in controlled drug delivery . Med. Plast. Biomater , 4 : 34 – 44 .
  • Ravi Kumar , M.N.V. 2000 . Nano and Microparticles as Controlled Drug Delivery Devices . J. Pharm. Pharm. Sci. , 3 ( 2 ) : 234 – 258 .
  • van der Lubben , I.M. 2001 . Chitosan microparticles for oral vaccination:: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches . Biomaterials , 22 ( 7 ) : 687 – 694 .
  • LaVan , D.A. , McGuire , T. and Langer , R. 2003 . Small-scale systems for in vivo drug delivery . Nat. Biotech. , 21 ( 10 ) : 1184 – 1191 .
  • Park , J.H. 2010 . Targeted delivery of low molecular drugs using chitosan and its derivatives . Adv. Drug Del. Rev. , 62 ( 1 ) : 28 – 41 .
  • Tiyaboonchai , W. 2003 . Chitosan nanoparticles: A promising system for drug delivery . Naresuan Univ. J. , 11 ( 3 ) : 51 – 66 .
  • Janes , K.A. , Calvo , P. and Alonso , M.J. 2001 . Polysaccharide colloidal particles as delivery systems for macromolecules . Adv. Drug Del. Rev. , 47 ( 1 ) : 83 – 97 .
  • Bodmeier , R. , Chen , H. and Paeratakul , O. 1989 . A novel approach to the delivery of microparticles or nanoparticles . Pharm. Res. , 6 : 413 – 417 .
  • Berthold , A. , Cremer , K. and Kreuter , J. 1996 . Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs . J. Control. Release , 39 : 17 – 25 .
  • Zhi , J. 2006 . In situ preparation of magnetic chitosan/Fe3O4 composite nanoparticles in tiny pools of water-in-oil microemulsion . Reactive Func. Polym. , 66 ( 12 ) : 1552 – 1558 .
  • Ohya , Y. 1994 . Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity . J. Macromol. Sci. A , 31 ( 5 ) : 629 – 642 .
  • de Salamanca , A.E. 2006 . Chitosan Nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance . Invest. Ophthalmol. Vis. Sci. , 47 ( 4 ) : 1416 – 1425 .
  • Sharma , V. and Ali , M. 2007 . Preparation and characterization of chitosan nanoparticles for nose to brain delivery of a cholinesterase inhibitor . Indian Journal of Pharmaceutical Sciences , 69 ( 5 ) : 712
  • Lee , D.-W. 2006 . Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline . Respir Res. , 7 ( 1 ) : 112 – 121 .
  • Zhang , H. 2004 . Monodisperse Chitosan Nanoparticles for Mucosal Drug Delivery . Biomacromolecules , 5 ( 6 ) : 2461 – 2468 .
  • Li , P. 2008 . Chitosan-Alginate nanoparticles as a novel drug delivery system for nifedipine . Int. J. Biomed. Sci. , 4 ( 3 ) : 221 – 228 .
  • Chen , J.-Y. 2007 . Depositing Cu2O of different morphology on chitosan nanoparticles by an electrochemical method . Carbohyd. Polym. , 67 ( 4 ) : 623 – 629 .
  • Agnihotri , S.A. and Aminabhavi , T.M. 2007 . Chitosan Nanoparticles for Prolonged Delivery of Timolol Maleate . Drug Develop. Ind. Pharm. , 33 ( 11 ) : 1254 – 1262 .
  • de Campos , A. 2004 . Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity . Pharm. Res. , 21 ( 5 ) : 803 – 810 .
  • Alonso , M.J. and Sánchez , A. 2010 . The potential of chitosan in ocular drug delivery . J. Pharm. and Pharmacology , 55 ( 11 ) : 1451 – 1463 .
  • Fernández-Urrusuno , R. 1999 . Enhancement of nasal absorption of insulin using chitosan nanoparticles . Pharm. Res. , 16 ( 10 ) : 1576 – 1581 .
  • Sun , Y. 2009 . Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy . Nanotechnology , 20 ( 13 ) : 135102
  • Huang , M. , Khor , E. and Lim , L.-Y. 2004 . Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation . Pharm. Res. , 21 ( 2 ) : 344 – 353 .
  • Huang , M. 2002 . Uptake of FITC-chitosan nanoparticles by A549 cells . Pharm. Res. , 19 ( 10 ) : 1488 – 1494 .
  • Xing , K. 2008 . Antibacterial activity of oleoyl-chitosan nanoparticles: A novel antibacterial dispersion system . Carbohyd. Polym. , 74 ( 1 ) : 114 – 120 .
  • Vila , A. 2002 . Design of biodegradable particles for protein delivery . J. Control. Release , 78 ( 1–3 ) : 15 – 24 .
  • Gan , Q. and Wang , T. 2007 . Chitosan nanoparticle as protein delivery carrier--Systematic examination of fabrication conditions for efficient loading and release . Colloid Surf. B , 59 ( 1 ) : 24 – 34 .
  • Hu , Y. 2002 . Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles . Biomaterials , 23 ( 15 ) : 3193 – 3201 .
  • Wang , J. 2010 . Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles . Biomaterials,. , 31 ( 15 ) : 4426 – 4433 .
  • Mansouri , S. 2006 . Characterization of folate-chitosan-DNA nanoparticles for gene therapy . Biomaterials , 27 ( 9 ) : 2060 – 2065 .
  • Borges , O. 2008 . Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles . Eur. J. Pharm. Biopharm. , 69 ( 2 ) : 405 – 416 .
  • Csaba , N. , Garcia-Fuentes , M. and Alonso , M. 2009 . Nanoparticles for nasal vaccination . Adv. Drug Del. Rev. , 61 ( 2 ) : 140 – 157 .
  • Khatri , K. 2008 . Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B . Int. J. Pharm. , 354 ( 1–2 ) : 235 – 241 .
  • Wilson , B. 2010 . Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine . Nanomed: Nanotechnol. Biol. Med. , 6 ( 1 ) : 144 – 152 .
  • Wang , X. , Chi , N. and Tang , X. 2008 . Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting . Eur. J. Pharm. Biopharm. , 70 ( 3 ) : 735 – 740 .
  • Grenha , A. , Seijo , B. and Remuñán-López , C. 2005 . Microencapsulated chitosan nanoparticles for lung protein delivery . Eur. J. Pharm. Sci. , 25 ( 4–5 ) : 427 – 437 .
  • Colonna , C. 2008 . Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy . Eur. J. Pharm. Biopharm. , 70 ( 1 ) : 58 – 65 .
  • Banerjee , T. 2002 . Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles . Int. J. Pharm. , 243 ( 1–2 ) : 93 – 105 .
  • Alishahi , A. 2011 . Shelf life and delivery enhancement of vitamin C using chitosan nanoparticles . Food Chem. , 126 ( 3 ) : 935 – 940 .
  • Wu , Y. 2005 . Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate . Int. J. Pharm. , 295 ( 1–2 ) : 235 – 245 .
  • Huang , X. 2009 . Preparation and pharmacodynamics of low-molecular-weight chitosan nanoparticles containing insulin . Carbohyd. Polym. , 76 ( 3 ) : 368 – 373 .
  • Wang , Y. 2008 . Adsorption of bovin serum albumin (BSA) onto the magnetic chitosan nanoparticles prepared by a microemulsion system . Bioresource Technol. , 99 ( 9 ) : 3881 – 3884 .
  • Rejinold , N. 2010 . Biodegradable and thermo-sensitive chitosan-g-poly (N-vinylcaprolactam) nanoparticles as a 5-fluorouracil carrier . Carbohyd. Polym. , 83 ( 2 ) : 776 – 786 .
  • Qi , J. 2010 . Nanoparticles with dextran/chitosan shell and BSA/chitosan Coreá-áDoxorubicin loading and delivery . Int. J. Pharm. , 393 ( 1 ) : 177 – 185 .
  • Akhlaghi , S.P. 2010 . Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines . Nanomed.: Nanotechnol. Biol. Med. , 6 ( 5 ) : 689 – 697 .
  • Parveen , S. 2010 . Enhanced antiproliferative activity of carboplatin-loaded chitosan-alginate nanoparticles in a retinoblastoma cell line . Acta Biomater. , 6 ( 8 ) : 3120 – 3131 .
  • Min , K.H. 2008 . Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy . J. Control. Release , 127 ( 3 ) : 208 – 218 .
  • Ajun , W. 2009 . Preparation of aspirin and probucol in combination loaded chitosan nanoparticles and in vitro release study . Carbohyd. Polym. , 75 ( 4 ) : 566 – 574 .
  • Zhi , J. , Wang , Y. and Luo , G. 2005 . Adsorption of diuretic furosemide onto chitosan nanoparticles prepared with a water-in-oil nanoemulsion system . Reactive Func. Polym. , 65 ( 3 ) : 249 – 257 .
  • Dev , A. 2010 . Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications . Carbohyd. Polym. , 80 ( 3 ) : 833 – 838 .
  • Amorim , C.d.M. 2010 . Antioxidant idebenone-loaded nanoparticles based on chitosan and N-carboxymethylchitosan . Nanomed.: Nanotechnol. Biol. Med. , 6 ( 6 ) : 745 – 752 .
  • Oyarzun-Ampuero , F.A. 2009 . Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma . Int. J. Pharm. , 381 ( 2 ) : 122 – 129 .
  • Anitha , A. 2011 . Preparation; characterization; in vitro drug release and biological studies of curcumin loaded dextran sulfate-chitosan nanoparticles . Carbohyd. Polym. , 84 ( 3 ) : 1158 – 1164 .
  • Keawchaoon , L. and Yoksan , R. 2011 . Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles . Colloid Surface B , 84 ( 1 ) : 163 – 171 .
  • Hafner , A. 2009 . Melatonin-loaded lecithin/chitosan nanoparticles: Physicochemical characterisation and permeability through Caco-2 cell monolayers . Int. J. Pharm. , 381 ( 2 ) : 205 – 213 .
  • Patil , S.B. and Sawant , K.K. Chitosan microspheres as a delivery system for nasal insufflation . Colloid Surface B , 84 ( 2 ) 384 – 389 .
  • Paolicelli , P. 2009 . Chitosan nanoparticles for drug delivery to the eye. Expet Opin. Drug Deliv. , 6 ( 3 ) : 239 – 253 .
  • Sinha , V.R. 2004 . Chitosan microspheres as a potential carrier for drugs . Int. J. Pharm. , 274 ( 1–2 ) : 1 – 33 .
  • Basu , S.K. , Kavitha , K. and Rupeshkumar , M. 2010 . Evaluation of Ketorolac Tromethamine Microspheres by Chitosan/Gelatin B Complex Coacervation . Sci. Pharma. , 78 ( 1 ) : 79
  • Roy , S. 2009 . Effect of method of preparation of chitosan microspheres of mefenamic acid . Int. J. Pharm. Sci. Drug Res. , 1 ( 1 ) : 36 – 42 .
  • Liu , X. 2004 . Swelling behaviour of alginate-chitosan microcapsules prepared by external gelation or internal gelation technology . Carbohyd. Polym. , 56 ( 4 ) : 459 – 464 .
  • Wittaya-areekul , S. , Kruenate , J. and Prahsarn , C. 2006 . Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone . Int. J. Pharm. , 312 ( 1–2 ) : 113 – 118 .
  • Shanmuganathan , S. 2008 . Preparation and characterization of chitosan microspheres for doxycycline delivery . Carbohyd. Polym. , 73 ( 2 ) : 201 – 211 .
  • Zhang , Y. 2011 . Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin . Eur. J. Pharm. Biopharm. , 77 ( 1 ) : 11 – 19 .
  • El-Hameed , M. and Kellaway , I. 1997 . Preparation and in vitro characterisation of mucoadhesive polymeric microspheres as intra-nasal delivery systems . Eur. J. Pharm. Biopharm. , 44 ( 1 ) : 53 – 60 .
  • Longo , W.E. 1982 . Preparation of hydrophilic albumin microspheres using polymeric dispersing agents . J. Pharm. Sci. , 71 ( 12 ) : 1323 – 1328 .
  • Jameela , S. and Jayakrishnan , A. 1995 . Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: Studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle . Biomaterials , 16 ( 10 ) : 769 – 775 .
  • Gupta , K.C. and Jabrail , F.H. 2007 . Glutaraldehyde cross-linked chitosan microspheres for controlled release of centchroman . Carbohyd. Res. , 342 ( 15 ) : 2244 – 2252 .
  • Amidi , M. 2010 . Chitosan-based delivery systems for protein therapeutics and antigens . Adv. Drug Delivery Rev. , 62 ( 1 ) : 59 – 82 .
  • Giunchedi , P. 2002 . Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres . Eur. J. Pharm. Biopharm. , 53 ( 2 ) : 233 – 239 .
  • Van der Lubben , I. 2001 . Chitosan microparticles for oral vaccination::: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches . Biomaterials , 22 ( 7 ) : 687 – 694 .
  • Lorenzo-Lamosa , M.L. 1998 . Design of microencapsulated chitosan microspheres for colonic drug delivery . J. Control. Release , 52 ( 1–2 ) : 109 – 118 .
  • van der Lubben , I. 2001 . Chitosan and its derivatives in mucosal drug and vaccine delivery . Eur. J. Pharm. Sci. , 14 ( 3 ) : 201 – 207 .
  • Huang , X. 2009 . Preparation and pharmacodynamics of low-molecular-weight chitosan nanoparticles containing insulin . Carbohyd. Polym. , 76 ( 3 ) : 368 – 373 .
  • Amidi , M. 2010 . Chitosan-based delivery systems for protein therapeutics and antigens . Adv. Drug Delivery Rev. , 62 ( 1 ) : 59 – 82 .
  • Kang , M. , Cho , C. and Yoo , H. 2009 . Application of chitosan microspheres for nasal delivery of vaccines . Biotechnol. Adv. , 27 ( 6 ) : 857 – 865 .
  • Remuñán-López , C. 1998 . Development of new chitosan-cellulose multicore microparticles for controlled drug delivery . Eur. J. Pharm. Biopharm. , 45 ( 1 ) : 49 – 56 .
  • Simonoska Crcarevska , M. , Glavas Dodov , M. and Goracinova , K. 2008 . Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa . Eur. J. Pharm. Biopharm. , 68 ( 3 ) : 565 – 578 .
  • Jose , S. 2011 . Colon specific chitosan microspheres for chronotherapy of chronic stable angina . Colloids Surface B , 83 ( 2 ) : 277 – 283 .
  • Díez-Municio , M. 2011 . Supercritical CO2 impregnation of lactulose on chitosan: A comparison between scaffolds and microspheres form . The Journal of Supercritical Fluids. , 57 ( 1 ) : 73 – 79 .
  • Maestrelli , F. 2008 . Microspheres for colonic delivery of ketoprofen-hydroxypropyl-[beta]-cyclodextrin complex . Eur. J. Pharm. Sci. , 34 ( 1 ) : 1 – 11 .
  • Zhang , W. 2008 . Chitosan and β -cyclodextrin microspheres as pulmonary sustained delivery systems . J. Wuhan U. Technol. Mater. Sci. , 23 ( 4 ) : 541 – 546 .
  • Vasconcellos , F. , Goulart , G. and Beppu , M. 2011 . Production and characterization of chitosan microparticles containing papain for controlled release applications . Powder Technol. , 205 ( 1 ) : 65 – 70 .
  • Harris , R. Chitosan nanoparticles and microspheres for the encapsulation of natural antioxidants extracted from Ilex paraguariensis . Carbohyd. Polym. , 84 ( 2 ) 803 – 806 .
  • Guliyeva , Ü. 2006 . Chitosan microparticles containing plasmid DNA as potential oral gene delivery system . Eur. J. Pharm. Biopharm. , 62 ( 1 ) : 17 – 25 .
  • Anumansirikul , N. 2008 . UV-screening chitosan nanocontainers: increasing the photostability of encapsulated materials and controlled release . Nanotechnology , 19 : 205101
  • Gomaa , Y. 2010 . Chitosan microparticles incorporating a hydrophilic sunscreen agent . Carbohyd. Polym. , 81 ( 2 ) : 234 – 242 .
  • Günbeyaz , M. 2010 . Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1) . Eur. J. Pharm. Sci. , 41 ( 3–4 ) : 531 – 545 .
  • Ko , J. 2003 . Chitosan microparticle preparation for controlled drug release by response surface methodology . J. Microencapsul. , 20 ( 6 ) : 791 – 797 .
  • Bayomi , M.A. 1998 . Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique . Pharm. Acta Helvetiae , 73 ( 4 ) : 187 – 192 .
  • Dhawan , S. and Singla , A. 2003 . Nifedipine loaded chitosan microspheres prepared by emulsification phase-separation . Biotech. Histochem. , 78 ( 5 ) : 243 – 254 .
  • Zhang , C. 2008 . Preparation and characterization of galactosylated chitosan coated BSA microspheres containing 5-fluorouracil . Carbohyd. Polym. , 72 ( 3 ) : 390 – 397 .
  • Glavas Dodov , M. 2009 . Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: Development and in vitro characterization . Int. J. Pharm. , 381 ( 2 ) : 166 – 175 .
  • Dubey , R. and Parikh , R. 2004 . Two-stage optimization process for formulation of chitosan microspheres . AAPS PharmSciTech , 5 ( 1 ) : 20 – 28 .
  • Chandy , T. 2001 . Development of poly (Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis . Drug Del. , 8 ( 2 ) : 77 – 86 .
  • Bazzo , G. , Lemos-Senna , E. and Pires , A. 2009 . Poly (3-hydroxybutyrate)/chitosan/ketoprofen or piroxicam composite microparticles: Preparation and controlled drug release evaluation . Carbohyd. Polym. , 77 ( 4 ) : 839 – 844 .
  • Mladenovska , K. 2007 . Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles . Int. J. Pharm. , 342 ( 1–2 ) : 124 – 136 .
  • Amiji , M. 2007 . Tetracycline-containing Chitosan Microspheres for Local Treatment of Helicobacter pylori Infection . Cellulose , 14 ( 1 ) : 3 – 14 .
  • Ventura , C. 2008 . Chitosan microspheres for intrapulmonary administration of moxifloxacin: Interaction with biomembrane models and in vitro permeation studies . Eur. J. Pharm. Biopharm. , 68 ( 2 ) : 235 – 244 .
  • Jameela , S. 1998 . Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system . J. Control. Release , 52 ( 1–2 ) : 17 – 24 .
  • Babensee , J. , McIntire , L. and Mikos , A. 2000 . Growth factor delivery for tissue engineering . Pharm. Res. , 17 ( 5 ) : 497 – 504 .
  • Babu , V. , Hosamani , K. and Aminabhavi , T. 2008 . Preparation and in-vitro release of chlorothiazide novel pH-sensitive chitosan-N, N′-dimethylacrylamide semi-interpenetrating network microspheres . Carbohyd. Polym. , 71 ( 2 ) : 208 – 217 .
  • Akbuga , J. and Durmaz , G. 1994 . Preparation and evaluation of cross-linked chitosan microspheres containing furosemide . Int. J. Pharm. , 111 ( 3 ) : 217 – 222 .
  • Angadi , S. , Manjeshwar , L. and Aminabhavi , T. 2010 . Interpenetrating Polymer Network Blend Microspheres of Chitosan and Hydroxyethyl Cellulose for Controlled Release of Isoniazid . Int. J. Biol. Macromol. , 47 ( 2 ) : 171 – 179 .
  • Manca , M. 2008 . Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles . Colloid Surfaces B , 67 ( 2 ) : 166 – 170 .
  • Guerrero , S. 2010 . Characterization and in vivo evaluation of ketotifen-loaded chitosan microspheres . Carbohyd. Polym. , 79 ( 4 ) : 1006 – 1013 .
  • Roy , S. 2009 . Polymers in Mucoadhesive Drug-Delivery Systems: A Brief Note . Design. Monom. Polym. , 12 : 483 – 495 .
  • Mishra , R. 2008 . Preparation and characterization of amidated pectin based hydrogels for drug delivery system . J. Mater. Sci. , 19 ( 6 ) : 2275 – 2280 .
  • Sutar , P. 2008 . Development of pH sensitive polyacrylamide grafted pectin hydrogel for controlled drug delivery system . J. Mater. Sci. , 19 ( 6 ) : 2247 – 2253 .
  • Pal , K. , Banthia , A.K. and Majumdar , D.K. Effect of heat treatment of starch on the properties of the starch hydrogels . Mater. Lett. , 62 ( 2 ) 215 – 218 .
  • Pal , K. , Banthia , A.K. and Majumdar , D.K. 2007 . Preparation and Characterization of Polyvinyl Alcohol–Gelatin Hydrogel Membranes for Biomedical Applications . AAPS PharmSciTech. , 8 ( 1 ) : E1 – E5 .
  • Pal , K. , Banthia , A.K. and Majumdar , D.K. 2006 . Polyvinyl alcohol-gelatin patches of salicylic acid: Preparation, characterization and drug release studies . J. Biomater. Appl. , 21 ( 1 ) : 75 – 91 .
  • Pal , K. , Banthia , A. and Majumdar , D. 2007 . Biomedical evaluation of polyvinyl alcohol–gelatin esterified hydrogel for wound dressing . J. Mater. Sci. , 18 ( 9 ) : 1889 – 1894 .
  • Pal , K. , Banthia , A.K. and Majumdar , D.K. 2006 . Preparation of Novel pH-Sensitive Hydrogels of Carboxymethyl Cellulose Acrylates: A Comparative Study . Mater. Manuf. Processes , 21 ( 8 ) : 877 – 882 .
  • Pal , K. , Banthia , A.K. and Majumdar , D.K. 2006 . Development of carboxymethyl cellulose acrylate for various biomedical applications . Biomed. Mater. , 1 ( 2 ) : 85 – 91 .
  • Pal , K. , Banthia , A.K. and Majumdar , D.K. 2006 . Characterization of prepared corn starch-based hydrogel membranes . J. Appl. Biomater. Biomech. , 4 ( 1 ) : 38 – 44 .
  • Pal , K. , Banthia , A.K. and Majumdar , D.K. 2006 . Preparation of transparent starch based hydrogel membrane with potential application as wound dressing . Trends Biomater. Artif. Organs , 20 ( 1 ) : 59 – 67 .
  • Bhattarai , N. , Gunn , J. and Zhang , M. 2010 . Chitosan-based hydrogels for controlled, localized drug delivery . Adv. Drug Del. Rev. , 62 ( 1 ) : 83 – 99 .
  • Amin , S. , Rajabnezhad , S. and Kohli , K. 2009 . Hydrogels as potential drug delivery systems . Sci. Res. Essays , 4 ( 11 ) : 1175 – 1183 .
  • Ta , H.T. 2009 . Chitosan-dibasic orthophosphate hydrogel: A potential drug delivery system . Int. J. Pharm. , 371 ( 1–2 ) : 134 – 141 .
  • Jeong , B. , Kim , S.W. and Bae , Y.H. 2002 . Thermosensitive sol-gel reversible hydrogels . Adv. Drug Del. Rev. , 54 ( 1 ) : 37 – 51 .
  • Bhattarai , N. 2005 . PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release . J. Control. Release , 103 ( 3 ) : 609 – 624 .
  • Berger , J. 2004 . Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications . Eur. J. Pharm. Biopharm. , 57 ( 1 ) : 19 – 34 .
  • Tanabe , T. , Okitsu , N. and Yamauchi , K. 2004 . Fabrication and characterization of chemically crosslinked keratin films . Mater. Sci. Eng.: C , 24 ( 3 ) : 441 – 446 .
  • Huang , R.-H. 2007 . Hexamethylene diisocyanate crosslinking 2-hydroxypropyltrimethyl ammonium chloride chitosan/poly(acrylonitrile) composite nanofiltration membrane . J. Appl. Polym. Sci. , 105 ( 2 ) : 673 – 679 .
  • Ono , K. 2000 . Photocrosslinkable chitosan as a biological adhesive . J. Biomed. Mater. Res. , 49 ( 2 ) : 289 – 295 .
  • Hussain , A.A. 1998 . Intranasal drug delivery . Adv. Drug Del. Rev. , 29 ( 1–2 ) : 39 – 49 .
  • Ugwoke , M.I. 2005 . Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives . Adv. Drug Del. Rev. , 57 ( 11 ) : 1640 – 1665 .
  • Kublik , H. and Vidgren , M.T. 1998 . Nasal delivery systems and their effect on deposition and absorption . Adv. Drug Del. Rev. , 29 ( 1–2 ) : 157 – 177 .
  • Dodane , V. , Amin Khan , M. and Merwin , J.R. 1999 . Effect of chitosan on epithelial permeability and structure . Int. J. Pharm. , 182 ( 1 ) : 21 – 32 .
  • Nakamura , K. 1999 . Uptake and release of budesonide from mucoadhesive, pH-sensitive copolymers and their application to nasal delivery . J. Control. Release , 61 ( 3 ) : 329 – 335 .
  • Wu , J. 2007 . A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system . Biomaterials , 28 ( 13 ) : 2220 – 2232 .
  • Agrawal , A.K. 2010 . Development and characterization of in situ gel system for nasal insulin delivery . Pharmazie , 65 ( 3 ) : 188 – 193 .
  • Fang , J.-Y. 2008 . Temperature-sensitive hydrogels composed of chitosan and hyaluronic acid as injectable carriers for drug delivery . Eur. J. Pharma. Biopharm. , 68 ( 3 ) : 626 – 636 .
  • Risbud , M.V. 2000 . pH-sensitive freeze-dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery . J. Control. Release , 68 ( 1 ) : 23 – 30 .
  • Schaffhausen , N. , Tijsma , E. and Hissong , B. 2008 . Injectable chitosan-based hydrogels for drug delivery after ear-nose-throat surgery . J. Control. Release , 132 ( 3 ) : e47 – e48 .
  • Ta , H.T. 2009 . A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy . Biomaterials , 30 ( 27 ) : 4815 – 4823 .
  • Ek , E.T.H. , Dass , C.R. and Choong , P.F.M. 2006 . Pigment epithelium-derived factor: A multimodal tumor inhibitor . Molecul. Cancer Therap. , 5 ( 7 ) : 1641 – 1646 .
  • Ta , H.T. 2009 . A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma . Biomaterials , 30 ( 21 ) : 3605 – 3613 .
  • Han , H.D. 2008 . A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine . Int. J. Pharm. , 350 ( 1–2 ) : 27 – 34 .
  • Seo , S.H. 2009 . Chitosan hydrogel containing GMCSF and a cancer drug exerts synergistic anti-tumor effects via the induction of CD8+ T cell-mediated anti-tumor immunity . Clin. Exp. Metastasis , 26 ( 3 ) : 179 – 187 .
  • Ramakrishnan , R. 2010 . Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice . J. Clin. Invest. , 120 ( 4 ) : 1111 – 1124 .
  • Fouda , M.M.G. 2009 . Use of chitosan/polyamine biopolymers based cotton as a model system to prepare antimicrobial wound dressing . Int. J. Diab. Mellitus , 1 ( 1 ) : 61 – 64 .
  • Jayakumar , R. Biomaterials based on chitin and chitosan in wound dressing applications . Biotechnol. Adv.. , 29 ( 3 ) 322 – 337 .
  • Ueno , H. , Mori , T. and Fujinaga , T. 2001 . Topical formulations and wound healing applications of chitosan . Adv. Drug Del. Rev. , 52 ( 2 ) : 105 – 115 .
  • Yang , X. 2008 . Investigation of PVA/ws-chitosan hydrogels prepared by combined [gamma]-irradiation and freeze-thawing . Carbohyd. Polym. , 73 ( 3 ) : 401 – 408 .
  • Zhao , L. 2003 . Synthesis of antibacterial PVA/CM-chitosan blend hydrogels with electron beam irradiation . Carbohyd. Polym. , 53 ( 4 ) : 439 – 446 .
  • Martin , L. 2003 . Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels . Eur. J. Pharm. Biopharm. , 55 ( 1 ) : 35 – 45 .
  • Senel , S. 2000 . Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery . Int. J. Pharm. , 193 ( 2 ) : 197 – 203 .
  • Feng , J. , Zhao , L. and Yu , Q. 2004 . Receptor-mediated stimulatory effect of oligochitosan in macrophages . Biochem. Biophys. Res. Comm. , 317 ( 2 ) : 414 – 420 .
  • Shantha , K.L. and Harding , D.R.K. 2000 . Preparation and in-vitro evaluation of poly[N-vinyl-2-pyrrolidone-polyethylene glycol diacrylate]-chitosan interpolymeric pH-responsive hydrogels for oral drug delivery . Int. J. Pharm. , 207 ( 1–2 ) : 65 – 70 .
  • Mitra , S. 2001 . Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier . J. Control. Release , 74 ( 1–3 ) : 317 – 323 .
  • Ishihara , M. 2006 . Chitosan hydrogel as a drug delivery carrier to control angiogenesis . J. Artif. Organs , 9 ( 1 ) : 8 – 16 .
  • Ruel-Gariépy , E. 2004 . A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel . Eur. J. Pharm. Biopharm. , 57 ( 1 ) : 53 – 63 .
  • Patel , V.R. and Amiji , M.M. 1996 . Preparation and characterization of freeze-dried chitosan-poly(ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach . Pharm. Res. , 13 ( 4 ) : 588 – 593 .
  • Makarand , V. and Risbud , R.R.B. 2000 . Polyacrylamide-chitosan hydrogels: In vitro biocompatibility and sustained antibiotic release studies . Drug Del. , 7 ( 2 ) : 69 – 75 .
  • Yao , K.D. 1995 . Investigation of pH-sensitive drug delivery system of chitosan/gelatin hybrid polymer network . Polym. Int. , 38 ( 1 ) : 77 – 82 .
  • Berger , J. 2004 . Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications . Eur. J. Pharm. Biopharm. , 57 ( 1 ) : 35 – 52 .
  • Dash , M. 2011 . Chitosan--A versatile semi-synthetic polymer in biomedical applications . Prog. Polym. Sci. , 36 ( 8 ) : 981 – 1014 .
  • Jiskoot , W. 2009 . Immunological Risk of Injectable Drug Delivery Systems . Pharm. Res. , 26 ( 6 ) : 1303 – 1314 .
  • Liu , Y. 2011 . Preparation and characterization of [alpha]-galactosidase-loaded chitosan nanoparticles for use in foods . Carbohyd. Polym. , 83 ( 3 ) : 1162 – 1168 .
  • Wang , Q. 2010 . Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery . Nanomed.: Nanotechnol. Biol. Med. , 6 ( 2 ) : 371 – 381 .
  • Mao , S. , Sun , W. and Kissel , T. 2010 . Chitosan-based formulations for delivery of DNA and siRNA . Adv. Drug Del. Rev. , 62 ( 1 ) : 12 – 27 .
  • Patil , S.B. and Sawant , K.K. 2011 . Chitosan microspheres as a delivery system for nasal insufflation . Colloid Surfaces B , 84 ( 2 ) : 384 – 389 .
  • Ying , X.-Y. 2011 . Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin . Carbohyd. Polym. , 84 ( 4 ) : 1357 – 1364 .
  • Jingou , J. 2011 . Preparation, characterization of hydrophilic and hydrophobic drug in combine loaded chitosan/cyclodextrin nanoparticles and in vitro release study . Colloid Surfaces B , 83 ( 1 ) : 103 – 107 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.